奥贝胆酸在肝损害患者的剂量选择及FDA定量审评的考虑
高丽丽, 陈蕊, 李禄金, 郑青山
Dose selection of obeticholic acid in hepatic impairment patients and the review consideration of FDA
GAO Lili, CHEN Rui, LI Lujin, ZHENG Qingshan
中国临床药理学与治疗学
.
2021, (7): 760
-767
.
DOI: 10.12092/j.issn.1009-2501.2021.07.006
